LEADER 01927oam  2200517   450 
001 9910715457103321
005 20210614144401.0
035   $a(CKB)5470000002511473
035   $a(OCoLC)1243899589
035   $a(EXLCZ)995470000002511473
100   $a20210330d2021      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 13$aAn Act to Direct the Comptroller General of the United States to Complete a Study on Barriers to Participation in Federally Funded Cancer Clinical Trials by Populations That Have Been Traditionally Underrepresented in Such Trials
210  1$a[Washington, D.C.] :$c[U.S. Government Publishing Office],$d[2021]
215   $a1 online resource (2 unnumbered pages)
300   $a"Jan. 5, 2021 (H.R. 1966)."
300   $a"134 Stat. 4894."
300   $a"Public Law 116-291."
606   $aCancer$xResearch$zUnited States
606   $aHeLa cells
606   $aMinorities$xHealth and hygiene$zUnited States
606   $aCancer$xResearch$2fast
606   $aHeLa cells$2fast
606   $aMinorities$xHealth and hygiene$2fast
607   $aUnited States$2fast
608   $aStatutes and codes.$2fast
608   $aStatutes and codes.$2lcgft
615  0$aCancer$xResearch
615  0$aHeLa cells.
615  0$aMinorities$xHealth and hygiene
615  7$aCancer$xResearch.
615  7$aHeLa cells.
615  7$aMinorities$xHealth and hygiene.
801  0$bGPO
801  1$bGPO
801  2$bOCLCO
801  2$bOCLCF
801  2$bGPO
906   $aBOOK
912   $a9910715457103321
996   $aAn Act to Direct the Comptroller General of the United States to Complete a Study on Barriers to Participation in Federally Funded Cancer Clinical Trials by Populations That Have Been Traditionally Underrepresented in Such Trials$93541825
997   $aUNINA